Collectively, these data indicated that the miR-222-3p inhibitor protected IECs from oxidative stress by activating the BRG1/Nrf2/HO-1 pathway in AOM/DSS-induced CAC mice, thereby inhibiting the inflammatory-cancer transition. The gene discussed is SMARCA4; the disease is cancer.